Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for ...
Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US ...
In response to the growing burden of non-communicable diseases (NCDs), health experts have called for stronger cardiac and neurological care ...
The new facility will help organisations across Australia and Oceania navigate technology challenges and turn AI ...
U.S.–Israel–GCC strategy, Hormuz risk, oil shock, global supply chain impact and escalation analysis. As of March 27, 2026—one month after the February 28 assassination of Supreme Leader Ayatollah Ali ...
A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity ...
At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic ...
New medical advancements are making surgery less invasive for those with Aortic Valve Disease. When the aortic heart valve ...
Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable ...
Early valve replacement surgery for very severe asymptomatic aortic stenosis was tied to lower long-term mortality risk ...
This marks the first dedicated transcatheter heart valve approved for high-risk patients with symptomatic severe AR.
JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. And it gets to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results